These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 9795136

  • 21. Poly(ADP-ribose) Polymerase inhibitors preserve nicotinamide adenine dinucleotide and adenosine 5'-triphosphate pools in DNA-damaged cells: mechanism of stimulation of unscheduled DNA synthesis.
    Sims JL, Berger SJ, Berger NA.
    Biochemistry; 1983 Oct 25; 22(22):5188-94. PubMed ID: 6317018
    [Abstract] [Full Text] [Related]

  • 22. Selegiline is neuroprotective in primary brain cultures treated with 1-methyl-4-phenylpyridinium.
    Koutsilieri E, Chen TS, Rausch WD, Riederer P.
    Eur J Pharmacol; 1996 Jun 13; 306(1-3):181-6. PubMed ID: 8813631
    [Abstract] [Full Text] [Related]

  • 23. Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrine.
    Fuller RW, Hemrick-Luecke SK, Robertson DW.
    Biochem Pharmacol; 1988 Sep 01; 37(17):3343-7. PubMed ID: 3135812
    [Abstract] [Full Text] [Related]

  • 24. Central noradrenergic neurotoxicity of DSP4 in mice. Studies on the neuroprotective potential of the poly(ADP-ribose) polymerase inhibitor, benzamide.
    Marien M, Cosi C.
    Ann N Y Acad Sci; 1999 Sep 01; 890():336-9. PubMed ID: 10668439
    [No Abstract] [Full Text] [Related]

  • 25. Interleukine-1beta and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization.
    Shen YQ, Hebert G, Lin LY, Luo YL, Moze E, Li KS, Neveu PJ.
    J Neuroimmunol; 2005 Jan 01; 158(1-2):14-25. PubMed ID: 15589033
    [Abstract] [Full Text] [Related]

  • 26. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), cyperquat (MPP+) and paraquat on isolated mitochondria from rat striatum, cortex and liver.
    Thakar JH, Hassan MN.
    Life Sci; 1988 Jan 01; 43(2):143-9. PubMed ID: 3260653
    [Abstract] [Full Text] [Related]

  • 27. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on ATP levels of mouse brain synaptosomes.
    Scotcher KP, Irwin I, DeLanney LE, Langston JW, Di Monte D.
    J Neurochem; 1990 Apr 01; 54(4):1295-301. PubMed ID: 2313288
    [Abstract] [Full Text] [Related]

  • 28. Persistent depletion of striatal dopamine and cortical norepinephrine in mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-3-pyridinol (MPTP-3-OL), an analog of MPTP.
    Hemrick-Luecke SK, Robertson DW, Krushinski JH, Fuller RW.
    Life Sci; 1992 Apr 01; 50(8):573-82. PubMed ID: 1736028
    [Abstract] [Full Text] [Related]

  • 29. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M, Morissette M, Tanguay B, Callier S, Di Paolo T.
    Synapse; 2003 Jan 01; 47(1):10-4. PubMed ID: 12422368
    [Abstract] [Full Text] [Related]

  • 30. Mitochondrial toxins in models of neurodegenerative diseases. II: Elevated zif268 transcription and independent temporal regulation of striatal D1 and D2 receptor mRNAs and D1 and D2 receptor-binding sites in C57BL/6 mice during MPTP treatment.
    Smith TS, Trimmer PA, Khan SM, Tinklepaugh DL, Bennett JP.
    Brain Res; 1997 Aug 15; 765(2):189-97. PubMed ID: 9313891
    [Abstract] [Full Text] [Related]

  • 31. Prolonged alterations in canine striatal dopamine metabolism following subtoxic doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 4'-amino-MPTP are linked to the persistence of pyridinium metabolites.
    Johannessen JN, Sobotka TJ, Weise VK, Markey SP.
    J Neurochem; 1991 Sep 15; 57(3):981-90. PubMed ID: 1677682
    [Abstract] [Full Text] [Related]

  • 32. H MRS identifies lactate rise in the striatum of MPTP-treated C57BL/6 mice.
    Koga K, Mori A, Ohashi S, Kurihara N, Kitagawa H, Ishikawa M, Mitsumoto Y, Nakai M.
    Eur J Neurosci; 2006 Feb 15; 23(4):1077-81. PubMed ID: 16519673
    [Abstract] [Full Text] [Related]

  • 33. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine pretreatment attenuates methamphetamine-induced dopamine toxicity.
    Kita T, Saraya T, Konishi N, Matsunari Y, Shimada K, Nakamura M, O'Hara K, Wagner GC, Nakashima T.
    Pharmacol Toxicol; 2003 Feb 15; 92(2):71-80. PubMed ID: 12747576
    [Abstract] [Full Text] [Related]

  • 34. Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism.
    Muñoz A, Rey P, Guerra MJ, Mendez-Alvarez E, Soto-Otero R, Labandeira-Garcia JL.
    Neuropharmacology; 2006 Jul 15; 51(1):112-20. PubMed ID: 16678218
    [Abstract] [Full Text] [Related]

  • 35. Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice.
    Moy LY, Albers DS, Sonsalla PK.
    Brain Res; 1998 Apr 20; 790(1-2):264-9. PubMed ID: 9593931
    [Abstract] [Full Text] [Related]

  • 36. Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
    Lau YS, Trobough KL, Crampton JM, Wilson JA.
    Gen Pharmacol; 1990 Apr 20; 21(2):181-7. PubMed ID: 2332138
    [Abstract] [Full Text] [Related]

  • 37. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
    Clarke PB, Reuben M.
    Br J Pharmacol; 1995 Jan 20; 114(2):315-22. PubMed ID: 7881731
    [Abstract] [Full Text] [Related]

  • 38. Neuroprotective effects of a novel poly(ADP-ribose) polymerase-1 inhibitor, 2-[3-[4-(4-chlorophenyl)-1-piperazinyl] propyl]-4(3H)-quinazolinone (FR255595), in an in vitro model of cell death and in mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    Iwashita A, Yamazaki S, Mihara K, Hattori K, Yamamoto H, Ishida J, Matsuoka N, Mutoh S.
    J Pharmacol Exp Ther; 2004 Jun 20; 309(3):1067-78. PubMed ID: 14985416
    [Abstract] [Full Text] [Related]

  • 39. Differential effects of carboxyfullerene on MPP+/MPTP-induced neurotoxicity.
    Lin AM, Yang CH, Ueng YF, Luh TY, Liu TY, Lay YP, Ho LT.
    Neurochem Int; 2004 Jan 20; 44(2):99-105. PubMed ID: 12971912
    [Abstract] [Full Text] [Related]

  • 40. Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice.
    Vaglini F, Fascetti F, Tedeschi D, Cavalletti M, Fornai F, Corsini GU.
    Neurodegeneration; 1996 Jun 20; 5(2):129-36. PubMed ID: 8819133
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.